Aimmune Therapeutics, Inc.·5

Feb 14, 5:27 PM ET

Sheehy Douglas T. 5

5 · Aimmune Therapeutics, Inc. · Filed Feb 14, 2020

Insider Transaction Report

Form 5
Period: 2019-12-31
Transactions
  • Tax Payment

    Common Stock, $0.0001 par value

    2019-03-01$24.30/sh2,883$70,06442,785 total
Footnotes (3)
  • [F1]The reported sale was made pursuant to a pre-determined election to sell shares to cover tax withholding obligations in connection with the vesting of a previously reported equity award.
  • [F2]Includes 29,617 restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2018, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
  • [F3]Includes 12,500 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2019, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.

Documents

1 file
  • 5
    doc5.xmlPrimary

    FORM 5 SUBMISSION